Hologic, Inc. (NASDAQ: HOLX) shares traded at USD 68.22, registering a 0.31 point gain (+0.456%) in the latest session. This update outlines the company profile, market position, trading details, and what the stock movement means for investors.
Company overview
Hologic, Inc. is a U.S.-based medical technology company founded in 1985 and headquartered in Marlborough, Massachusetts. The firm develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical products focused on women’s health. Its operations span the United States, Europe, Asia-Pacific, and other international markets. The business is structured into four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
Products include the Aptima molecular assay line for infectious disease detection, breast imaging solutions such as 3D mammography systems, minimally invasive biopsy tools, and gynecological surgical devices. Additional offerings include bone density measurement systems and mini C-arm imaging for orthopedics. Distribution occurs through direct sales teams, independent distributors, and sales representatives.
Stock performance
Shares of HOLX closed at USD 68.22, marking a modest percentage increase of 0.456% for the day. The price movement reflects current investor sentiment, likely influenced by sector conditions and broader market activity. Technical indicators show a 52-week range between USD 51.90 and USD 84.39, which helps investors assess volatility and potential price ceilings or floors. The day’s trading volume of 1,158,395 shares is below the average volume of 1,917,640, indicating light trading relative to recent trends.
Hologic’s market capitalization stands at approximately USD 15.17 billion. This measure provides a quick view of the company’s total equity value in the market and is a common benchmark for comparing size among industry peers.
Market position and sector
Hologic operates within the “Medical – Instruments & Supplies” industry, part of the broader Healthcare sector. This positioning aligns the company with suppliers of diagnostic and surgical devices. Market demand is influenced by healthcare spending trends, innovation cycles, and regulatory changes.
The focus on women’s health gives Hologic a defined niche, potentially reducing direct competition and fostering specialization. The sector has shown resilience due to consistent demand for diagnostic and treatment tools in hospitals and clinics worldwide.
Governance and leadership
Stephen P. MacMillan serves as Chairman, President, and Chief Executive Officer. His leadership oversees strategic direction, operational efficiency, and portfolio diversification. Governance factors such as executive experience and decision-making frameworks can influence investor confidence.
The company employs approximately 7,063 full-time staff, reflecting its operational scale. Headquarters are located at 250 Campus Drive, Marlborough, MA, serving as the center of administrative and R&D activities.
Key financial data
Recent trading data highlights several key metrics:
- Share Price: USD 68.22 (as of latest session)
- Market Capitalization: USD 15,173,443,418
- Dividend: 0 (no recent dividend payment)
- Volume: 1,158,395 shares traded
- Average Volume: 1,917,640 shares
- 52-Week Range: USD 51.90 – USD 84.39
The absence of a dividend suggests that Hologic may be reinvesting earnings back into the business rather than distributing to shareholders. Investors often regard this decision as supportive of growth initiatives, though dividend-focused portfolios may avoid non-yielding stocks. The range provides a context to evaluate price movement relative to historical highs and lows.
Trading details
Hologic trades on the NASDAQ Global Select Market under ticker HOLX. Its International Securities Identification Number (ISIN) is US4364401012 and its CUSIP is 436440101. These identifiers facilitate accurate trade execution and settlement in global markets. The Central Index Key (CIK) with the U.S. Securities and Exchange Commission is 0000859737, linking to regulatory filings and disclosures.
FAQ
- Does Hologic pay dividends? Currently, Hologic does not issue dividends, as indicated by the last dividend value of 0.
- Where is Hologic traded? It is listed on the NASDAQ Global Select Market under ticker HOLX.
- How many employees does Hologic have? The company has 7,063 full-time employees.
- What sector and industry does Hologic belong to? Sector: Healthcare. Industry: Medical – Instruments & Supplies.
- Who is the CEO? Stephen P. MacMillan serves as CEO, President, and Chairman.
Conclusion
Hologic, Inc. presents a profile of stable operations within a specialized healthcare niche. The recent share price movement, market capitalization, and trading volume provide a snapshot of its current market stance. While the lack of a dividend might deter yield-focused investors, reinvestment strategies could position the company for sustained innovation and growth.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Investors should conduct independent research before making investment decisions.
Announcement
For full information about the company, see the link below.
https://www.hologic.com